Weijian Guo

发表

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Zhe Zhang, Yusheng Wang, Xiaodong Zhu, 2021, Asia-Pacific journal of clinical oncology.

Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors

L. Shen, Jian Li, S. Qin, 2021, Journal of Hematology & Oncology.

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

Yi He, Wen-hua Li, J. Ying, 2022, Cancer communications.

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma

Kai Xue, Lan Wang, Jin-jia Chang, 2021, Cell Death & Disease.

AKP and GGT level can provide early prediction of first-line treatment efficacy in colorectal cancer patients with hepatic metastases.

Mingzhu Huang, Wen-hua Li, Wen Zhang, 2021, Biomarkers in medicine.

Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer

Yun Liu, Shenglin Huang, Sijie Sun, 2022, Cell Death & Disease.

Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study

W. Li, Ying Cheng, Y. Ba, 2021, BioDrugs.

Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.

D. Ji, Xiaoying Zhao, Mingzhu Huang, 2021, Acta biochimica et biophysica Sinica.

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

Jian-hua Chang, Jialei Wang, Tianshu Liu, 2017, BMC Cancer.

Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study

Jinjia Chang, Mingzhu Huang, Wen-hua Li, 2021, Therapeutic advances in medical oncology.

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy

Xiaodong Zhu, Xiaoying Zhao, J. Zou, 2022, Frontiers in Oncology.

Three-Tier Prognostic Index in Young Adults With Advanced Gastric Cancer

Xiaoping Zhao, Wen-hua Li, Xiaodong Zhu, 2021, Frontiers in Oncology.

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial

Jianfeng Luo, Zhe Zhang, Yusheng Wang, 2022, Therapeutic advances in medical oncology.

First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis with 3-year follow-up.

Ying Cheng, Y. Ba, Wen-Wei Hu, 2023, Journal of Clinical Oncology.

Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases

Xinxiang Li, Sijie Sun, Xiaodong Zhu, 2022, Frontiers in Oncology.

Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer

Ying Cheng, Jianming Xu, Changping Wu, 2021, OncoTargets and therapy.

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

Wei Li, F. Gao, Y. Ba, 2023, BMC Medicine.

Expression and significance of CD44 and p-AKT in pancreatic head cancer

Leizhen Zheng, Z. Xiaowei, Xiao-ping Li, 2015, World Journal of Surgical Oncology.

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy

Xiaodong Zhu, Xiaoying Zhao, Mingzhu Huang, 2022, Frontiers in Oncology.

First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis

Y. Ba, Wen-Wei Hu, Wei Li, 2022, International journal of cancer.

Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data

Xiaodong Zhu, Weijian Guo, Xiao-ying Zhao, 2024, Therapeutic advances in medical oncology.

Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c Study.

Weijian Guo, Huan Zhou, Xiaoyan Kang, 2024, Advances in therapy.

Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial

Zhe Zhang, Lei Yang, Xiaodong Zhu, 2023, Cancer biology & medicine.